Advertisement
UK markets closed
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • FTSE 250

    19,884.73
    +74.07 (+0.37%)
     
  • AIM

    743.26
    +1.15 (+0.15%)
     
  • GBP/EUR

    1.1698
    +0.0005 (+0.04%)
     
  • GBP/USD

    1.2634
    +0.0011 (+0.09%)
     
  • Bitcoin GBP

    55,539.32
    -237.78 (-0.43%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • DOW

    39,807.37
    +47.29 (+0.12%)
     
  • CRUDE OIL

    83.11
    -0.06 (-0.07%)
     
  • GOLD FUTURES

    2,254.80
    +16.40 (+0.73%)
     
  • NIKKEI 225

    40,369.44
    +201.37 (+0.50%)
     
  • HANG SENG

    16,541.42
    +148.58 (+0.91%)
     
  • DAX

    18,492.49
    +15.40 (+0.08%)
     
  • CAC 40

    8,205.81
    +1.00 (+0.01%)
     

FTSE 100 movers: HSBC rockets on domicile review, Astra hit by heartburn rival

LONDON (ShareCast) - HSBC topped the risers as it launched a review of its UK domicile in light of the changing regulatory landscape. Some media commentators suggested the announcement, carefully timed ahead of the general election, was politically motivated. After receiving some takeover interest in one of its divisions, BAE Systems (LSE: BA.L - news) was making gains on Friday, as it confirmed it was considering a disposal of its US-based manpower and services businesses, which operates in the US intelligence and security sector.

Mining stocks were tracking iron ore prices higher, including Anglo American (LSE: AAL.L - news) , Rio Tinto (Xetra: 855018 - news) , BHP Billiton (NYSE: BBL - news) , Glencore (Xetra: A1JAGV - news) and Antofagasta (LSE: ANTO.L - news) .

Astrazeneca (NYSE: AZN - news) led the fallers as sales dipped 6% in the first quarter, which was slightly less-than-expected. The pharmaceutical giant's trading was negatively impacted by the launch of a generic rival to its stomach acid pill Nexium in the US.

Despite solid first quarter results, shares in Pearson (Xetra: 858266 - news) were in the red as the publishing and education group's chairman announced he would be stepping down. The company said it was in-line to meet its full-year expectations after a solid start to the year, reiterating its full-year guidance for adjusted earnings per share of between 75p and 80p this year, up from 66.7 in 2014.

ADVERTISEMENT

Aberdeen Asset Management (Other OTC: ABDNF - news) dipped on a downgrade from analysts at Bank of America (Swiss: BAC.SW - news) -Merrill Lynch to 'underperform'.

Risers HSBC Holdings (Xetra: HBC2.DE - news) (HSBA) 630.20p +2.94% BHP Billiton (BLT) 1,576.00p +2.91% BAE Systems (BA.) 518.00p +2.88% Glencore (GLEN) 311.75p +2.79% Anglo American (AAL) 1,090.50p +2.68% Rio Tinto (RIO) 3,025.50p +2.28% Barratt Developments (LSE: BDEV.L - news) (BDEV) 541.00p +2.17% CRH (CRH (NYSE: CRH - news) ) 1,894.00p +2.10% Barclays (Swiss: BARC.SW - news) (BARC) 263.55p +1.97% Taylor Wimpey (LSE: TW.L - news) (TW.) 168.90p +1.93% Fallers AstraZeneca (Swiss: AZN.SW - news) (AZN) 4,694.00p -2.82% Dixons Carphone (LSE: DC.L - news) (DC.) 430.00p -1.56% Aberdeen Asset Management (ADN) 480.10p -1.52% Reed Elsevier (REL) 1,113.00p -1.42% Weir Group (WEIR) 1,758.00p -1.40% Meggitt (MGGT) 542.50p -1.36% Shire Plc (Xetra: S7E.DE - news) (SHP) 5,560.00p -1.33% International Consolidated Airlines Group SA (CDI) (IAG) 570.50p -1.30% Pearson (PSON) 1,384.00p -1.28% Land Securities Group (LAND) 1,259.00p -1.25%